Improving T cell therapies for pancreatic cancer
Research Testbed 1
This study is looking for ways to make T cell therapies work better for people with pancreatic cancer by figuring out how to help these immune cells move and act more effectively in the tough environment of pancreatic tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10991436 on NIH RePORTER |
What this research studies
This research investigates how to enhance the effectiveness of T cell therapies specifically for pancreatic ductal adenocarcinoma, a highly aggressive form of cancer. It focuses on understanding the unique fibrotic and immunosuppressive environment of pancreatic tumors that hinders T cell infiltration and function. By utilizing advanced imaging techniques, engineered environments, and mathematical modeling, the research aims to develop strategies that improve T cell movement and activity within tumors, potentially leading to better treatment outcomes for patients. The approach includes both preclinical studies and innovative cell engineering methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic ductal adenocarcinoma who are seeking innovative treatment options.
Not a fit: Patients with early-stage pancreatic cancer or those who do not have pancreatic ductal adenocarcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for pancreatic cancer, improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promise in enhancing T cell therapies for other cancers, but this specific approach for pancreatic cancer is still being explored.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Provenzano, Paolo — University of Minnesota
- Study coordinator: Provenzano, Paolo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.